Mount Sinai Institutes for Clinical and Translational Sciences
Mount Sinai Institutes for Clinical and Translational Sciences
批准号:
8060566
负责人:
Barbara T. Murphy
金额:
$3.11万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-14 至 2014-03-31
关键词:
Basic ScienceCaregiversClinicalClinical InvestigatorClinical ResearchClinical SciencesClinical TrialsClinical Trials DesignCollaborationsCommunitiesComplexConsultationsCountryDentistryDentistsDevelopmentDiscipline of NursingDoctor of PhilosophyEducationEngineeringEnvironmentEthical IssuesFacultyFosteringFundingFutureGeneral PopulationGoalsGrantHealth BenefitHealth ProfessionalHealth Services ResearchHealthcareHome environmentHospitalsInformation NetworksInstitutesInstitutionInterdisciplinary StudyLaboratoriesMaster of Public HealthMaster of ScienceMedical StudentsMedicineMentorsMethodologyModelingNursesParticipantPatient CarePatientsPharmacistsPharmacy facilityPhysiciansPostdoctoral FellowPrincipal InvestigatorProceduresProfessional EducationRecruitment ActivityResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch Project GrantsResearch TrainingResourcesRewardsSECTM1 geneScientific Advances and AccomplishmentsScientistSocial WorkSocial WorkersStrategic PlanningStructureTechnologyTherapeuticTrainingTraining SupportTraining and EducationTranslatingTranslational ResearchTranslationsUnited States National Institutes of Healthbench to bedsidecareercareer developmentclinical practicegraduate studentimprovedinnovationinterdisciplinary collaborationinterestmedical schoolsmultidisciplinarynovelprogramsstandard of caretrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Despite great scientific advances over the past decade, the translation of these discoveries to the benefit of
patients has been hampered by a number of traditional barriers. The overall goal of the Mount Sinai
Institutes of Clinical & Translational Sciences is to establish a new research paradigm at Mount Sinai,
which will create an integrated multidisciplinary environment that will enable translation of cutting-edge
research more quickly and easily from "bench-to-bedside-to-implementation" in the community; train and
create an "academic home" for the clinical and translational investigators of tomorrow; and supply the
governance, facilities, resources and opportunities needed to elevate the clinical research enterprise so that
clinical investigators can take full advantage of Mount Sinai's Translational Research Institutes and potential
collaborators in Mount Sinai Hospital and its affiliates, the School of Medicine and partnering institutions, and
other CTSA programs around the country. This transformation will be achieved by fulfilling the following
Specific Aims: (1) redesign the institutional research enterprise infrastructure and governance by integrating
research functions across administrative, departmental and intellectual boundaries, enhancing and
promoting interactions between basic scientists and clinical investigators, and streamlining administrative
procedures to facilitate the start-up of clinical trials and the dissemination of results; (2) establish a
Translational Discoveries Program to facilitate and expedite clinical research by providing consultation,
oversight and facilities for clinical and translational research, engaging the surrounding community and our
affiliates to rapidly translate health benefits to the general population, and developing new methodologies to
improve clinical trial design and reduce participant burden; (3) train and support the translational
investigators of tomorrow by overseeing a multi-disciplinary, doctoral degree-granting program in clinical and
translational research for all health care professionals, developing a program to recruit, enhance career
development and retain clinical and translational researchers, providing an academic home where new
collaborations can be formulated; (4) establish an Experimental Therapeutics& Technologies Program to
stimulate the development of new methodologies in clinical and translational research by developing an
institution-wide mentored program to identify and develop novel clinical and translational research projects;
and (5) establish an institution-wide biomedical information infrastructure that can connect basic researchers,
clinical researchers, caregivers and laboratories with an integrated network of information.
RELEVANCE (See irtstructions):
The establishment of the Mount Sinai Institutes of Clinical & Translational Sciences would create an
effective, efficient and centralized research administrative structure, foster and reward interdisciplinary
collaborations, educate and retain the clinical and translational investigators of the future, enable translation
of basic scientific discoveries into clinical practice, and deliver to our diverse community new therapies and a
standard of care that would have been unimaginable even five years ago.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An intronic locus determines SHROOM3-expression and potentiates renal allograft fibrosis
-
批准号:8964994
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2015
-
负责人:Barbara T. Murphy
-
依托单位:
An intronic locus determines SHROOM3-expression and potentiates renal allograft fibrosis
-
批准号:9749960
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2015
-
负责人:Barbara T. Murphy
-
依托单位:
Genomics of Chronic Renal Allograft Rejection
-
批准号:8529741
-
项目类别:
-
资助金额:$45.28万
-
财政年份:2012
-
负责人:Barbara T. Murphy
-
依托单位:
Genomics of Chronic Renal Allograft Rejection
-
批准号:8100582
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2010
-
负责人:Barbara T. Murphy
-
依托单位:
Mount Sinai Institutes for Clinical and Translational Sciences
-
批准号:8060556
-
项目类别:
-
资助金额:$602.45万
-
财政年份:2009
-
负责人:Barbara T. Murphy
-
依托单位:
GENOMICS OF CHRONIC RENAL ALLOGRAFT REJECTION
-
批准号:7953702
-
项目类别:
-
资助金额:$0.29万
-
财政年份:2009
-
负责人:Barbara T. Murphy
-
依托单位:
Mount Sinai Institutes for Clinical and Translational Sciences
-
批准号:8060582
-
项目类别:
-
资助金额:$85.59万
-
财政年份:2009
-
负责人:Barbara T. Murphy
-
依托单位:
Genomics of Chronic Renal Allograft Rejection
-
批准号:7924421
-
项目类别:
-
资助金额:$52.89万
-
财政年份:2009
-
负责人:Barbara T. Murphy
-
依托单位:
Genomics of Chronic Renal Allograft Rejection
-
批准号:7273709
-
项目类别:
-
资助金额:$157.67万
-
财政年份:2006
-
负责人:Barbara T. Murphy
-
依托单位:
Genomics of Chronic Renal Allograft Rejection
-
批准号:7664558
-
项目类别:
-
资助金额:$164.82万
-
财政年份:2006
-
负责人:Barbara T. Murphy
-
依托单位:
Genomics of Chronic Renal Allograft Rejection
-
批准号:7487826
-
项目类别:
-
资助金额:$160.11万
-
财政年份:2006
-
负责人:Barbara T. Murphy
-
依托单位:
Genomics of Chronic Renal Allograft Rejection
-
批准号:7124517
-
项目类别:
-
资助金额:$165.99万
-
财政年份:2006
-
负责人:Barbara T. Murphy
-
依托单位:
Genomics of Chronic Renal Allograft Rejection
-
批准号:7911742
-
项目类别:
-
资助金额:$164.86万
-
财政年份:2006
-
负责人:Barbara T. Murphy
-
依托单位:
CLINICAL, IMUNOLOGIC AND PHARMACOLOGIC CONSEQUENCES OF SOLID ORGAN (KIDNEY) T
-
批准号:7202475
-
项目类别:
-
资助金额:$0.72万
-
财政年份:2005
-
负责人:Barbara T. Murphy
-
依托单位:
CLINICAL, IMMUNOLOGIC AND PHARMACOLOGIC CONSEQUENCES OF
-
批准号:7044854
-
项目类别:
-
资助金额:$0.73万
-
财政年份:2004
-
负责人:Barbara T. Murphy
-
依托单位:
Immunomodulation by MHC Class II Peptides
-
批准号:6511338
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2001
-
负责人:Barbara T. Murphy
-
依托单位:
Immunomodulation by MHC Class II Peptides
-
批准号:6866597
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2001
-
负责人:Barbara T. Murphy
-
依托单位:
Immunomodulation by MHC Class II Peptides
-
批准号:6632318
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2001
-
负责人:Barbara T. Murphy
-
依托单位:
Immunomodulation by MHC Class II Peptides
-
批准号:6319235
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2001
-
负责人:Barbara T. Murphy
-
依托单位:
Immunomodulation by MHC Class II Peptides
-
批准号:6705019
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2001
-
负责人:Barbara T. Murphy
-
依托单位:
海外基金